AdaptVac collaborates with GTP Bioways for its cVLP based malaria vaccineJun 20, 2024 | Press releaseread more
Lovaltech set to produce the first clinical batches of its innovative vaccine thanks to GTP BiowaysOct 3, 2023 | Press releaseread more
GTP Bioways strengthens its bioproduction capacities with the opening of a new microbial production unitSep 25, 2023 | Press releaseread more
LinKinVax completes first batch production of “PanCov”, its next generation multi-variant vaccine against covid and other coronaviruses, in collaboration with GTP BiowaysJul 20, 2023 | Press releaseread more
GTP Bioways is opening two new biopharmaceutical production unitsJun 26, 2023 | Press releaseread more
Genother, l’excellence en thérapie génique, labellisé Biocluster du Plan France 2030May 23, 2023 | Press releaseread more
GTP Bioways increases its mammalian production capacity with the opening of a new GMP manufacturing suiteApr 6, 2023 | Press releaseread more
Texcell & GTP Bioways – A business partnership to provide extended services to biopharmaceutical companiesMar 8, 2023 | Press releaseread more
Polygon Therapeutics & GTP Bioways – Cell line development for a novel antibodyFeb 28, 2023 | Press releaseread more